Financials
- Market Capitalization 592.22 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.22
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2825 | TECX Tectonic Therapeutic, Inc. - Common Stock | 30.76 USD | +2.81% | -14.17% | +4.31% | +79.36% | 601.34 M USD | ||
| 2853 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.63 USD | -0.71% | -4.90% | +5.83% | -38.87% | 559.89 M USD | ||
| 2865 | CAPR Capricor Therapeutics, Inc. - Common Stock | 9.48 USD | +2.16% | -1.66% | +127.34% | +58.00% | 551.16 M USD | ||
| 2870 | OVID Ovid Therapeutics Inc. - Common Stock | 2.80 USD | +0.72% | -0.71% | +11.11% | +117.05% | 546.83 M USD |